![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 403/12 | (2006.01) |
A61P 31/14 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
A61K 31/4196 | (2006.01) | ||
A61K 45/06 | (2006.01) |
(11) | Number of the document | 3601266 |
(13) | Kind of document | T |
(96) | European patent application number | 18715612.0 |
Date of filing the European patent application | 2018-03-29 | |
(97) | Date of publication of the European application | 2020-02-05 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
(46) | Date of publication of the claims translation | 2021-07-12 |
(86) | Number | PCT/EP2018/058079 |
Date | 2018-03-29 |
(87) | Number | WO 2018/178240 |
Date | 2018-10-04 |
(30) | Number | Date | Country code |
17164048 | 2017-03-31 | EP |
(72) |
KESTELEYN, Bart Rudolf Romanie, BE
BONFANTI, Jean-Francois , FR
COESEMANS, Erwin, BE
RABOISSON, Pierre Jean-Marie Bernard, BE
MARCHAND, Arnaud Didier M, BE
BARDIOT, Dorothée Alice Marie-Eve, BE
|
(73) |
Janssen Pharmaceuticals, Inc.,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
Katholieke Universiteit Leuven, Waaistraat 6, bus 5105, 3000 Leuven, BE |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Pakeisti indolino dariniai, kaip dengės viruso replikacijos inhibitoriai |
SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |
Payment date | Validity (years) | Amount | |
2023-03-24 | 6 | 139.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-03-29 |